\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
September 1: On Thursday, the European pharmaceutical regulator subsidized two separate COVID-19 vaccine boosters to date to target the Omicron variant and evolved through rivals Moderna and Pfizer-BioNTech, as the region prepares to roll out injections to prevent infections in winter.
The new so-called bivalent vaccines fight the BA. 1 edition of Omicron and the virus first detected in China.
The recommendations are aimed at other people over the age of 12 who have obtained at least one number one covid-19 vaccine, the European Medicines Agency (EMA) said.
The latest green light will be presented to the European Commission for approval, which is expected to take a position quickly.
(Natalie Grover edited through Raissa Kasolowsky)